WILMINGTON, DE — Enovis Corporation (NYSE: ENOV), a prominent player in the medical technology sector, this week announced its successful acquisition of LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic leader known for its innovative portfolio of implant solutions. This strategic move marks a significant expansion for Enovis, further solidifying its standing in the fiercely competitive orthopedic reconstruction market.
The acquisition is poised to boost Enovis’s growth and margin expansion on a global scale. Lima’s complementary portfolio of surgical solutions and technologies, including 3D-printed Trabecular Titanium implants and a comprehensive revision offering in shoulders, will fortify Enovis’s foothold in the rapidly growing extremities market.
“We are excited to welcome Lima’s talented team to Enovis,” said Matt Trerotola, Chair, and Chief Executive Officer of Enovis. “The combination brings Enovis’s recon segment to $1 billion in revenues and creates a fast-growing innovator in the global orthopedic reconstruction market.”
By integrating Lima’s groundbreaking technologies and skilled workforce, Enovis aims to accelerate its growth trajectory, deliver a wider range of offerings to its customers, and create compounding value for its shareholders.
This latest development places Enovis at the forefront of the orthopedic market, bringing together the strengths of two industry leaders. As part of Enovis, Lima will continue to focus on restoring motion for patients through its innovative implant solutions, while benefitting from the resources and reach of a larger organization. The resulting synergy is set to redefine the landscape of the global orthopedic reconstruction market.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.